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Red Bull was introduced in Austria in 1987 and in the United States in 1997. Since then, the energy beverage 
(EB) market has grown exponentially.1 Hundreds of differ-
ent brands are now marketed, with caffeine content ranging 
from a modest 50 mg to an alarming 505 mg per can or bot-
tle.2 In the United States, Red Bull enjoyed a 65% share of 
the $650-million energy/power drink market in 2005, and its 
sales are growing at about 35% per year.3 The United States 
is the world’s largest consumer of EBs by volume, roughly 
290 million gallons in 2007, or 3.8 qt per person per year.2 
Consumption of EBs is most common among those aged 11 
to 35 years, and 24% to 57% of this age group reported that 
they drank an EB within the past few months.4
 Regulation of EBs, including content labeling and health 
warnings, differs across countries, with some of the laxest 
requirements existing in the United States.2 For instance, 
no EBs are banned in the United States, and EB compa-
nies can say whatever they want regarding energy and per-
formance effects. This is in stark contrast to countries in 
which some EBs have been banned, and companies are not 
allowed to outline the performance effects that their prod-
ucts may or may not provide.4 This absence of oversight 
has resulted in aggressive marketing of EBs, targeted pri-
marily toward young men and openly promoting psychoac-
tive, performance-enhancing, and stimulatory effects.1,4
 Alarmingly, EB consumption has been shown to be 
positively associated with high-risk behavior, including 
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Exercise is making a resurgence in many countries, given its ben-
efits for fitness as well as prevention of obesity. This trend has 
spawned many supplements that purport to aid performance, mus-
cle growth, and recovery. Initially, sports drinks were developed to 
provide electrolyte and carbohydrate replacement. Subsequently, 
energy beverages (EBs) containing stimulants and additives have 
appeared in most gyms and grocery stores and are being used in-
creasingly by “weekend warriors” and those seeking an edge in an 
endurance event. Long-term exposure to the various components 
of EBs may result in significant alterations in the cardiovascular 
system, and the safety of EBs has not been fully established. For 
this review, we searched the MEDLINE and EMBASE databases 
from 1976 through May 2010, using the following keywords: ener-
gy beverage, energy drink, power drink, exercise, caffeine, red bull, 
bitter orange, glucose, ginseng, guarana, and taurine. Evidence 
regarding the effects of EBs is summarized, and practical recom-
mendations are made to help in answering the patient who asks, 
“Is it safe for me to drink an energy beverage when I exercise?”
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marijuana use, sexual risk taking, fighting, failure to use 
seat belts, and taking risks on a dare, as well as with smok-
ing, drinking, problems stemming from alcohol abuse, and 
illicit drug use.5,6
 In an era in which Gatorade and Powerade, termed sport 
drinks (SDs) for the purposes of this article, have paved the 
way as optimal hydration fluids that boast superiority to 
water, uncertainty is growing with regard to where EBs fit 
and how they are consumed.7 Convenience stores now dis-
play EBs next to the SDs, which can mislead the consumer 
into thinking that they are similar products. Whereas SDs 
can indeed provide hydration and replenishment of elec-
trolytes and carbohydrates, the elevated levels of caffeine 
in EBs have diuretic effects, more pronounced in the first-
time user, that increase urinary output and natriuresis.8 Ad-
ditionally, EBs may have thermogenic effects.9 Moreover, 
EBs supply an amount of carbohydrate far beyond that rec-
ommended for physically active people, which can slow 
the rate at which fluid is absorbed into the bloodstream or 
lead to gastrointestinal distress.10 Finally, the effects due to 
the interaction of substances on which little research has 
been done (eg, glucuronolactone) are not well understood.
 This review of EBs describes the various ingredients, 
discusses their safety, and provides recommendations re-
garding their use. Although most research studies and ob-
servational data have come from athletics, our research 
query included studies and information involving nonath-
lete consumers. Also, the review differentiates between 
these populations and offers recommendations specific to 
each group.
METhoDS
A search of the English-language scientific literature was 
performed primarily by searching the MEDLINE and 
EMBASE databases and using the Google Internet search 
EnErgy BEvEragEs
Mayo Clin Proc.    •    November 2010;85(11):1033-1041    •    doi:10.4065/mcp.2010.0381    •    www.mayoclinicproceedings.com1034
For personal use. Mass reproduce only with permission from Mayo Clinic Proceedings.
engine for the period January 1976 through May 2010. For 
this search, we used keywords found in lead peer-reviewed 
articles and research outlining the current body of knowl-
edge on EBs. Keywords used in the search are energy bev-
erage, energy drink, power drink, exercise, caffeine, red 
bull, bitter orange, glucose, ginseng, guarana, and taurine. 
The bibliographies of articles were searched for relevant 
articles; links on Web sites containing published articles 
were searched for pertinent information. This review en-
deavored to bring the most pertinent research to light in 
order to present real-world recommendations to both the 
athletic community and the general population.
INGrEDIENTS oF EBs
The most common ingredient in EBs is caffeine, which is 
often combined with taurine, glucuronolactone, guarana, 
and B vitamins to form what manufacturers have called an 
“energy blend.”1 When higher doses of caffeine are com-
bined with these other substances currently blended in EBs, 
the subsequent effect cannot always be predicted; adverse 
effects have been reported, including cardiac arrest.11,12 The 
components of the 4 best-selling EBs are given in Table 1, 
and the specific ingredients are subsequently discussed in 
more detail.
 Well-performed research indicates that some of these 
substances are important for proper body function, but this 
does not mean that a person has a deficiency. Moreover, 
important questions regarding overall intake and subse-
quent adverse effects should come to mind as the reader 
progresses through this review. We have also included in-
formation on the bioavailability of each substance if the 
necessary research has been completed.
Caffeine
Caffeine, an adenosine receptor antagonist, is a stimulant 
that can influence the activity of neuronal control pathways 
in the central and peripheral nervous systems.13 It is the 
most common stimulant in EBs, with most EBs containing 
between 70 and 200 mg of caffeine per 16-oz serving. In 
comparison, an 8-oz cup of coffee contains 110 to 150 mg 
for drip, 65 to 125 mg for percolated, and 40 to 80 mg for 
instant; caffeinated beverages contain about 50 to 100 mg 
of caffeine.14 Caffeine is known as an ergogenic compound 
that raises the heart rate and blood pressure. Adverse ef-
fects typically manifest with ingestion higher than 200 mg 
of caffeine and include insomnia, nervousness, headache, 
tachycardia, arrhythmia, and nausea.14,15 The ergogenic ef-
fects of caffeine on athletic performance have been shown, 
and its broad range of metabolic, hormonal, and physi-
ologic effects has been described.16,17 Caffeine has been 
shown to be an effective ergogenic aid for endurance ath-
letes when ingested before and/or during exercise in mod-
erate quantities (3-6 mg/kg of body mass); abstaining from 
caffeine for at least 7 days before use will optimize the 
effect.16 Of note, caffeine appears on the list of substances 
banned by the International Olympic Committee.18 Of all 
the compounds analyzed in this review, caffeine is by far 
the most-researched in the literature.16
 The absolute bioavailability of orally administered caf-
feine was investigated in 10 healthy adult male volunteers 
aged 19 to 30 years.19 Participants received a 5-mg/kg dose 
of caffeine as either an aqueous oral solution or an intra-
venous infusion on separate occasions about 1 week apart 
in a randomized crossover fashion. Plasma samples were 
collected during the 24-hour period after each dose and as-
sayed for their caffeine content using a high-performance 
liquid chromatographic technique. The oral absorption was 
very rapid, with caffeine reaching a peak plasma concentra-
tion after 29.8 minutes, and the variation in the maximum 
plasma concentration was low at 10.0 µg/mL. The absolute 
bioavailability was assessed by comparing the areas under 
the plasma concentration vs time curves for the intravenous 
and oral doses of caffeine. The rapid absorption resulted 
in essentially complete bioavailability of the oral caffeine, 
with a plasma half-life varying from 2.7 to 9.9 hours, in-
dicating substantial variability in its elimination between 
participants.19
 Caffeine mobilizes fat stores and stimulates working 
muscles to use fat as a fuel, which delays depletion of mus-
cle glycogen and allows for prolonged exercise.20 The criti-
cal period in glycogen sparing appears to occur during the 
first 15 minutes of exercise, when caffeine has been shown 
to decrease glycogen utilization by as much as 50%. Thus, 
glycogen saved at the beginning is available during the lat-
er stages of exercise. Although the exact mechanism is still 
unclear, caffeine caused sparing in all the human studies in 
which muscle glycogen levels were measured. The effect 
on performance, which was observed in most experimental 
studies, was that participants were able to exercise longer 
before exhaustion occurred.20
 Caffeine binds to the adenosine class of G protein–cou-
pled receptors on the surface of heart muscle cells, which 
begins a second messenger system with cyclic adenosine 
monophosphate inside the cells and mimics the effects of 
epinephrine.21 The rate of glycolysis increases, which in-
creases the amount of adenosine triphosphate available for 
muscle contraction and relaxation.22 This can result in a 
positive inotropy and chronotropy, ie, a stronger and faster 
heartbeat. Caffeine immediately increases blood pressure 
and peripheral vascular resistance, in part because of sym-
pathetic stimulation. One group of investigators showed a 
significant effect of drinking caffeinated coffee on arterial 
tone and function, suggesting that caffeine immediately 
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TABLe 1. Comparison of Ingredients in Energy Beveragesa 
     Red Bull   Rockstar   Monster   Full Throttle
Calories 220 280 200 220
Carbohydrates 54 g 62 g 54 g 57 g
   Sucrose, glucose Sucrose, glucose Sucrose, glucose, sucralose, High-fructose corn syrup,
        maltodextrin  sucrose
Sodium Only listed as 80 mg sodium citrate 360 mg 160 mg
    sodium citrate   16% RDA Sodium citrate
       Sodium citrate, sodium chloride    
Caffeine 160 mg 160 mg Only listed as part of a 5000-mg 141 mg
     Part of a 1.35-g “energy blend”  “energy blend” Part of a 3000-mg “energy 
          blend”
Taurine 2000 mg 2000 mg 2000 mg Only listed as part of a
     Part of a 1.35-g “energy blend” Part of a 5000-mg “energy blend”  3000-mg “energy blend”
Glucuronolactone Only listed None listed Only listed as part of a 5000-mg None listed
   (1200 mg)b    “energy blend” 
Niacin (B
3
) 200% RDA 40 mg 40 mg 100% RDA
   Niacinamide 200% RDA 200% RDA Niacinamide
   (40 mg)b Niacinamide Niacinamide  
Inositol (B
8
) Only listed 50 mg Only listed as part of a 5000-mg None listed
     Part of a 1.35-g “energy blend”  “energy blend” 
Pyridoxine 500% RDA 4 mg 4 mg 200% RDA
  hydrochloride (B
6
) (10 mg)b 200% RDA 200% RDA 
Cyanocobalamin (B
12
) 160% RDA 12 µg 12 µg 200% RDA
   Listed as 200% RDA 200% RDA
    vitamin B
12 
   (10 µg)b 
Riboflavin (B
2
) None listed 6.8 mg 3.4 mg None listed
     400% RDA 200% RDA 
Pantothenic acid (B
5
) 100% RDA 20 mg None listed None listed
   Calcium  200% RDA
    pantothenate Calcium pantothenate
   (10 mg)b
Ginseng extract None listed 50 mg 400 mg Only listed as part of a
     Part of a 1.35-g “energy blend”    3000-mg “energy blend”
Guarana extract None listed 50 mg Only listed as part of a 5000-mg Only listed as part of a
     Part of a 1.35-g “energy blend”  “energy blend”  3000-mg “energy blend”
Ginkgo biloba  None listed 300 mg None listed None listed
 leaf extract   Part of a 1.35-g “energy blend”
Milk thistle extract None listed 40 mg None listed None listed
     Part of a 1.35-g “energy blend” 
l-carnitine None listed 50 mg Only listed as part of a 5000-mg Only listed as part of a
     Part of a 1.35-g “energy blend”  “energy blend”  3000-mg “energy blend”
         Carnitine fumarate
Sorbic acid None listed Yes Yes No
Sodium benzoate None listed Yes Yes Yes
     Benzoic acid Benzoic acid
Citric acid None listed Yes Yes Yes
Natural flavors Yes Yes Yes Yes
Artificial flavors Yes Yes None listed None listed
Coloring “Colors” “Caramel” “Color added” Blue 1, Red 40
a As listed on 16-oz can unless otherwise noted. RDA = recommended daily allowance. 
b This amount is not listed on the can; the corporate office was called and this was all the information given.
EnErgy BEvEragEs
Mayo Clin Proc.    •    November 2010;85(11):1033-1041    •    doi:10.4065/mcp.2010.0381    •    www.mayoclinicproceedings.com1036
For personal use. Mass reproduce only with permission from Mayo Clinic Proceedings.
increases arterial stiffness, with the effect being more pro-
nounced on aortic systolic and diastolic blood pressures 
than on the brachial artery.23
 The discussion on caffeine and hydration continues to 
evolve. A number of studies have examined the effects of 
ingesting a large dose of caffeine and found that urine out-
put was increased.24 Yet, the long-held conclusion that caf-
feine increases 24-hour urine output has been challenged, 
because most of the studies that established this conclusion 
involved persons who refrained from caffeine consumption 
before the analysis.25,26 The human body develops a toler-
ance to caffeine quickly, usually 3 to 5 days after regu-
lar use, and when this happens, it noticeably weakens the 
already limited diuretic effect of caffeine.26,27 Moreover, 
the human kidneys are masters at ensuring that proper ho-
meostatic conditions are maintained. Recent research now 
leans toward the ability of the body to maintain proper wa-
ter levels and overcome the mild diuretic effects of caffeine 
in long-term users.25,28 
 As the rest of the ingredients are reviewed herein, please 
note that in comparison with caffeine, each has had far 
fewer research studies performed.
Taurine
Taurine, a sulfur-containing amino acid, is the most abun-
dant intracellular amino acid in humans and a normal con-
stituent of the human diet.29
 A study of the pharmacokinetics of taurine was con-
ducted in 8 healthy male volunteers with a median age of 
28 years. After oral administration of 4 g of taurine in the 
fasting state, blood samples were taken at regular intervals, 
and plasma taurine concentration was measured by a modi-
fied high-performance liquid chromatographic technique. 
Maximum plasma taurine concentration was 86 mg/L 1.5 
hours after administration. Plasma elimination half-life and 
the ratio of clearance to bioavailability were 1.0 hour and 
21 L/h, respectively.30
 Taurine modulates skeletal muscle contractile function 
and may attenuate exercise-induced DNA damage, with 
some evidence showing the ability to improve exercise ca-
pacity and performance; however, this has not been defini-
tively demonstrated.4 Taurine has numerous other biological 
and physiologic functions, including bile acid conjugation 
and cholestasis prevention; antiarrhythmic, inotropic, and 
chronotropic effects; central nervous system neuromodula-
tion; retinal development and function; endocrine or meta-
bolic effects; and antioxidant and anti-inflammatory prop-
erties.31 Taurine also assists in cell membrane stabilization, 
osmoregulation, and detoxification.32 However, the amounts 
of taurine found in popular EBs are far below the amounts 
expected to deliver either therapeutic benefits or adverse 
events.14
GluCuronolaCTone
This is a naturally occurring substance produced in small 
amounts within the body. Supplementation with D-glu-
carates, including glucuronolactone, may favor the body’s 
natural defense mechanism for eliminating carcinogens 
and tumor promoters and their effects.33 Toxicokinetic 
data on glucuronolactone in rats, which show bioavailabil-
ity and lack of accumulation, with peak plasma levels 1 to 
2 hours after oral administration, are in accordance with 
the limited human data.34 Unfortunately, little research 
has been done in humans, and the current body of knowl-
edge on this substance is scant. Therefore, conclusions on 
whether this compound is harmful or beneficial cannot be 
made.
B ViTamins
The B vitamins are water-soluble vitamins required as co-
enzymes for proper cell function, especially mitochondrial 
function and energy production.35 B vitamins include thia-
mine, riboflavin, niacin, pantothenic acid, pyridoxine hy-
drochloride, biotin, inositol, and cyanocobalamin. Because 
EBs contain large amounts of sugar, these vitamins are 
touted as ingredients necessary to convert the added sugar 
to energy. Hence, the B vitamins are the “key” needed to 
unlock all the energy provided by the simple sugars in EBs, 
and this is the extra energy that EB companies claim their 
product can provide. An expansive amount of research has 
been done on the B vitamins, and we outline the specific 
functions each major B vitamin plays in the human body.
 Thiamine (vitamin B
1
) is essential for the oxidative de-
carboxylation of the multienzyme branched-chain α-keto 
acid dehydrogenase complexes of the citric acid cycle and 
thus serves as a coenzyme precursor of some key enzymes 
of carbohydrate metabolism.36 Riboflavin (vitamin B
2
) is 
required for the flavoenzymes of the respiratory chain and 
thus also supports energy metabolism involving fats, car-
bohydrates, and proteins.37
 The reduced form of nicotinamide adenine dinucle-
otide (NADH) is synthesized from niacin (vitamin B
3
). 
This coenzyme is required to supply protons for oxida-
tive phosphorylation and plays a major part in energy 
pro duction in cells.38 It also stimulates the production of 
such neurotransmitters as l-dopa, dopamine, serotonin, and 
norepinephrine.
 Pantothenic acid (vitamin B
5
) is required for coenzyme 
A, α-ketoglutarate, and pyruvate dehydrogenase forma-
tion, as well as fatty acid oxidation.35
  Pyridoxine hydrochloride (vitamin B
6
) is a coenzyme 
involved in amino acid and homocysteine metabolism, glu-
cose and lipid metabolism, neurotransmitter production, 
and DNA and RNA synthesis.39 Specifically, pyridoxine 
hydrochloride is involved in protein and red blood cell me-
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tabolism, is important for immune system function, and is 
needed to convert tryptophan to niacin.
 Biotin (vitamin B
7
) is the coenzyme of decarboxylases 
required for gluconeogenesis and fatty acid oxidation.35 
Inositol (formerly vitamin B
8
 but declassified as a vitamin 
because it is synthesized by the human body) exists in 9 
possible stereoisomers, of which the most common form is 
myo-inositol. It is part of cell membranes, plays a role in 
helping the liver process fats, and contributes to the func-
tion of muscles and nerves.40
 Cyanocobalamin (vitamin B
12
) helps maintain nerve 
cell function, is needed for production of DNA, and is im-
portant in red blood cell formation.35
Guarana
Also known as guaranine, Paullinia cupana, and Sapin-
daceae, guarana is a rainforest vine that was domesticated 
in the Amazon for its caffeine-rich fruits and has long been 
used by the Amazonians to increase awareness and energy.41 
Guarana seeds contain more caffeine than any other plant in 
the world, with levels ranging from 2% to 8%; guarana also 
contains the stimulants theobromine and theophylline.42 
The amounts of guarana found in popular EBs are below the 
amounts expected to deliver therapeutic benefits or cause 
adverse events.14 However, some young adults have been 
admitted to emergency departments with overdoses of caf-
feine after overindulging in guarana-based EBs.42
GinsenG
Ginseng is one of the most popular herbal supplements in 
the world and is used for treatment and prevention of many 
ailments. This adaptogen (a natural herb product said to 
increase the body’s resistance to stress, trauma, anxiety, 
and fatigue) is purported to increase energy, relieve stress, 
and increase memory by stimulating the hypothalamic 
and pituitary glands to secrete corticotropin. Athletes use 
ginseng for its alleged performance-enhancing attributes; 
however, a recent review concluded that enhanced physi-
cal performance after ginseng administration remains to 
be demonstrated.43 Adverse effects associated with ginseng 
include hypotension, edema, palpitations, tachycardia, ce-
rebral arteritis, vertigo, headache, insomnia, mania, vaginal 
bleeding, amenorrhea, fever, appetite suppression, pruri-
tus, cholestatic hepatitis, mastalgia, euphoria, and neonatal 
death.4 However, the amounts of ginseng found in EBs are 
far below the amounts expected to deliver therapeutic ben-
efits or cause adverse events.14
GinkGo BiloBa
Ginkgo biloba extract is derived from the leaves of the 
Ginkgo biloba tree and has been used in traditional Chinese 
medicine for centuries.44 Ginkgo biloba extract has been 
reported to have antioxidant properties, modify vasomotor 
function, reduce adhesion of blood cells to endothelium, 
inhibit activation of platelets and smooth muscle cells, af-
fect ion channels, and alter signal transduction.45 However, 
to date, no large, well-conducted randomized controlled 
trials have shown that it has important clinical effects in 
healthy or ill persons.44
l-CarniTine
This amino acid is made predominantly by the liver and 
kidneys to increase metabolism. Dietary supplementation 
with l-carnitine has been shown to increase maximal oxy-
gen consumption and lower the respiratory quotient, indi-
cating stimulation of lipid metabolism.46 Recent evidence 
indicates that l-carnitine plays a decisive role in prevent-
ing cellular damage and favorably affects recovery from 
exercise stress. Uptake of l-carnitine by blood cells may 
promote (1) stimulation of hematopoiesis, (2) inhibition 
of collagen-induced platelet aggregation, and (3) preven-
tion of programmed cell death in immune cells. There is 
evidence of a beneficial effect of l-carnitine supplementa-
tion in training, competition, and recovery from strenuous 
exercise and in regenerative athletics.46 No advantage ap-
pears to exist in giving an oral dose greater than 2 g at one 
time, because absorption studies indicate saturation at this 
dose.47
suGars
Sugars are the basic currency for energy in the body, with 
glucose being the key carbohydrate that can readily be 
oxidized by skeletal muscle for energy production. Often, 
EBs contain sugar (high-fructose corn syrup or sucrose). 
Administration of glucose or other carbohydrates before, 
during, and after prolonged exercise (>1 hour) has been 
shown to postpone fatigue, conserve muscle glycogen, and 
improve performance.48,49 Ingestion of moderately con-
centrated carbohydrate solutions (4%-8%) with the aim of 
achieving a carbohydrate intake of 60 to 70 g/h enhances 
prolonged exercise performance and is appropriate for op-
timizing energy and fluid delivery without causing adverse 
effects.50 However, the ergogenic effects of carbohydrate 
ingestion on performance during intermittent exercise such 
as competitive sports are less well established, although the 
evidence to date suggests diminished performance when 
carbohydrates are limited.48 The amount of sugar provid-
ed in one can (or 500 mL) of an EB is typically about 54 
g. A teaspoon of sugar weighs about 4 g, so a typical EB 
contains about 13 teaspoons, or just more than ¼ cup, of 
sugar.
 Long-term exposure of the body to excesses of simple 
sugars is associated with the development of obesity and 
insulin resistance. Pancreatic beta cells increase insulin 
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secretion in response to this reduction in insulin sensi-
tivity. Over time, in many individuals, the beta cells be-
come unable to secrete sufficient insulin to maintain nor-
mal blood glucose levels, leading to the development of 
diabetes.51
anTioxidanTs
During exercise, inflammation and oxidative stress are 
linked by means of muscle metabolism and muscle dam-
age.52 Antioxidants are purported to aid the body in the 
recovery phase and reduce damage to muscle cells.53 How-
ever, there is no convincing evidence that short-term or 
long-term exercise modifies antioxidant requirements, nor 
have significant effects been shown for supplementation in 
well-trained athletes.54
Do EBs Work AND ArE ThEy SAFE?
researCh issues
A number of factors relating to EB consumption may make 
good morbidity and mortality data difficult to ascertain. 
These include the following.
	 •	 The	 target	 market	 for	 EBs	 is	 people	 between	 15	 
and 30 years of age. This population is typically healthy 
and involved in activities and includes a higher proportion 
of sports enthusiasts and high-risk takers.
	 •	Because	 of	 the	many	 ingredients	 in	EBs,	 cause	 and	 
effect is difficult to assign to one specific ingredient. In-
deed, it may be the combination of ingredients that aug-
ments the effect.
	 •	Most	of	the	ingredients	are	available	over	the	counter	
and are unregulated in the United States. Thus, EBs are 
not under the jurisdiction of the US Food and Drug Ad-
ministration and therefore are not subject to the stringent 
requirements for safety and efficacy data before approval 
for human use.
	 •	 Binge	 drinking	 of	 EBs	 combined	 with	 alcohol	 is	 
common practice, again making causation difficult to assign.
	 •	Many	people	 consume	more	 than	 the	 recommended	
daily allowance of EBs. (Recommended daily allowance is 
one can.)
shorT-Term effeCTs
In addressing the question of safety, it is important to con-
sider both short-term and long-term effects of ingestion of 
EBs. Physiologic effects occur immediately after drinking 
the first dose.
 In one study, 15 healthy persons aged 18 to 40 years 
consumed 2 cans (500 mL) of a commercially available 
EB containing 1000 mg of taurine and 100 mg of caffeine, 






, glucuronolactone, and 
niacinamide, daily for 1 week; effects of the EB on their 
blood pressure, pulse, and electrocardiogram (ECG) were 
measured.55 The key effects were as follows.
	 •	Within	 4	 hours	 of	 EB	 consumption,	 the	 maximum	 
systolic blood pressure increased by 8% on day 1 and 10% 
on day 7.
	 •	Within	 2	 hours	 of	 EB	 consumption,	 the	 maximum	 
diastolic blood pressure increased by 7% on day 1 and 8% 
on day 7.
	 •	 Heart	 rate	 increased	 by	 8%	 on	 day	 1	 and	 11%	 on	 
day 7.
	 •	Throughout	 the	 study,	heart	 rates	 increased	between	 
5 and 7 beats/min, and systolic blood pressure increased by 
10 mm Hg after EB consumption.
	 •	No	clinically	important	ECG	changes	were	observed.
 The authors concluded that, although no clinically im-
portant ECG changes occurred, there were significant in-
creases in heart rate and blood pressure, and thus patients 
with hypertension should not consume this type of drink.55
 In a double-blind crossover study, 13 endurance-trained 
participants performed an exhaustive bout of endurance 
exercise at 3 different times.56 Before the exercise, they in-
gested the original Red Bull drink, a similar drink without 
taurine but containing caffeine, and a placebo drink with-
out caffeine or taurine. Echocardiography was performed 
before ingestion of the drinks, before exercise, 40 minutes 
after ingestion, and in the recovery period after exercise. 
Stroke volume was significantly influenced only in the Red 
Bull group (80±21 mL before ingestion vs 98±26 mL in 
the recovery period), mainly because of reduced end-sys-
tolic volume. Thus, this study shows that the original Red 
Bull increases cardiac contractility.56
 A double-blind study of 68 healthy college-aged stu-
dents showed that Red Bull reduced the changes in blood 
pressure during a stressful experience (cold pressor test) 
and increased participants’ pain threshold.57
 In a study of the effects of EBs on high-intensity run 
time-to-exhaustion in physically active university stu-
dents (n=17; 9 men; mean age, 21±4 years), sugar-free 
Red Bull did not influence high-intensity run time-to-
exhaustion.58 However, in a study of 6 male and 6 female 
trained cyclists (mean age, 27.3 years), improved cycling 
time-trial performance was noted after ingestion of a caf-
feinated EB.59
 In addition to these studies, several case reports on the 
immediate effects of EB ingestion have been published.
	 •	 Four	 documented	 cases	 of	 caffeine-associated	 death	
have been reported, as well as 5 separate cases of seizures 
associated with consumption of energy/power drinks.4,14
	 •	An	 otherwise	 healthy	 28-year-old	 man	 had	 cardiac	 
arrest after a day of motocross racing.11
	 •	A	 healthy	 18-year-old	 man	 died	 playing	 basketball	 
after drinking 2 cans of Red Bull.60
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	 •	 Postural	 tachycardia	 syndrome	 associated	 with	 a	 
vasovagal reaction was recorded in a young volleyball 
player after an excess intake of Red Bull as a refreshing 
energy/power drink, leading experts to suspect the drink as 
a possible cause of orthostatic intolerance.61
	 •	 Four	 cases	 of	 psychiatric	 effects	 on	 patients	 with	
known psychiatric illness were reported.4
	 •	One	case	of	suspected	anaphylaxis	was	reported.62
 Regarding fluid replacement in persons who do not 
typically ingest large amounts of caffeine, EBs deliver a 
considerable amount of caffeine, which can stimulate the 
kidneys to produce more urine. Thus, EBs can have a net 
dehydrating effect.63
lonG-Term effeCTs
Unfortunately, there are no long-term studies of the ef-
fects of caffeine, taurine, and glucuronolactone on the 
body.4 Energy beverages may exacerbate risk factors for 
heart disease because studies suggest that EBs may serve 
as a gateway to other forms of drug dependence.1 Nor-
way, Denmark, and France have banned the sale of Red 
Bull, partly in response to a study on rats that were fed 
taurine and exhibited bizarre behavior, including anxiety 
and self-mutilation.64
 Whether caffeine can cause hypertension and coronary 
artery disease is still controversial, but questions have been 
raised about its safety in patients with heart failure and 
arrhythmia.65 However, no clear association between cof-
fee and the risk of hypertension, myocardial infarction, or 
other cardiovascular diseases has been demonstrated.66
ComBininG eBs and alCohol
Many consumers are combining EBs with alcoholic drinks. 
These individuals are typically white men and intramural 
athletes, a group now termed “toxic jocks.”4 The conse-
quences can be tragic, as illustrated recently by Cleveland 
Browns wide receiver Donté Stallworth, who told police 
that he drank up to 4 shots of premium tequila and a can 
of Red Bull while partying with friends at a Miami Beach 
club, but did not feel drunk in the hours before he struck 
and killed a pedestrian with his car.67 The combination 
of EBs with alcohol can impair cognitive function and 
reduce symptoms of alcohol intoxication, including the 
depressant effects, thus increasing the probability of ac-
cidents and/or favoring the possibility of development of 
alcohol dependence.68,69 The combination might also in-
crease important arrhythmia in patients with underlying 
heart disease.70
 In late 2009, 100 scientists and physicians signed a peti-
tion that was delivered to the US Food and Drug Adminis-
tration asking for more regulation of increasingly popular 
EBs because their high caffeine content puts young drink-
ers at possible risk of caffeine intoxication and higher rates 
of alcohol-related injuries.2,5
 Clearly, more research is needed concerning the com-
bined effects of the substances listed in this report and, 
specifically, at the doses EBs provide. Teens and young 
adults, both athletes and nonathletes, are consuming EBs 
at an alarming rate; thus, we need to determine whether 
long-term use of EBs by this population will translate into 
deleterious effects later.
rECoMMENDATIoNS
On the basis of this review, we make the recommendations 
listed in Table 2.
 In summary, one can of an EB during one session is safe 
for most healthy individuals. However, excess consumption 
and consumption with other caffeine-containing beverages 
or alcohol may lead to adverse effects and possibly death. 
Patients with clinically relevant underlying medical con-
ditions, including heart disease and hypertension, should 
consult with their physician before drinking EBs.
CoNCLuSIoN
Coaches and athletic departments should take the initiative 
in addressing the issue of EBs with student athletes and 
in educating them about the effects and risks. The main 
ingredients of energy/power drinks are caffeine, taurine, 
glucuronolactone, B vitamins, guarana, ginseng, ginkgo bi-
TABLe 2. recommendations regarding Energy Beverage  
Consumption
For the nonathlete consumer
 Limit your consumption of EBs to no more than 500 mL, or 1 can  
  per day
 Do not mix EBs with alcohol; this can mask intoxication and may be  
  extremely dehydrating
 Rehydrate with water or an appropriately formulated SD after   
  exercise or intense physical activity
 If you experience an adverse reaction to an EB, report it to your  
  health care professional or organization
 If you are being treated for hypertension, avoid using EBs
 If you have a serious underlying medical condition, including   
  coronary artery disease, heart failure, or arrhythmia, consult with  
  your physician before using EBs
For the athlete participating in exercise lasting <1 h
 Do not use EBs 
 SDs appear safe, but we recommend against EBs while exercising  
  because of the possibility of dehydration, elevation of blood   
  pressure, and lack of equivocal benefits vs water or SDs
For the athlete participating in exercise lasting ≥1 h
 Do not use EBs
 SDs containing carbohydrates and electrolytes help prevent   
  dehydration and restore important minerals lost through   
  perspiration, and they produce better hydration than water
EB = energy beverage; SD = sport drink.
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loba, l-carnitine, sugars, antioxidants, and trace minerals. 
The negative effects of excess caffeine have been proven, 
but the positive effects of many of the other additives, such 
as taurine and glucuronolactone, remain unproven, as does 
the combined effect of these ingredients in EBs.
 Ingestion of EBs before an event or during training can 
have serious adverse effects, most notably restlessness and 
irritability; can increase blood pressure; and may result in 
dehydration. The long-term effects of EBs on the human 
body have not been established.
 Limited ingestion of EBs by healthy people is not likely 
to cause major adverse effects, but binge consumption or 
consumption with alcohol may lead to adverse events. Indi-
viduals with medical illnesses, especially underlying heart 
disease, should check with their physician before using 
EBs, because they may exacerbate their condition.
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